20194455

Source:http://linkedlifedata.com/resource/pubmed/id/20194455

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0003873, umls-concept:C0087111, umls-concept:C0205210, umls-concept:C0439230, umls-concept:C0439234, umls-concept:C0441655, umls-concept:C0521339, umls-concept:C0681842, umls-concept:C1261381
pubmed:issue	4
pubmed:dateCreated	2010-4-2
pubmed:abstractText	To investigate earlier prediction of future articular destruction in patients with early rheumatoid arthritis (RA).
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7501984
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antirheumatic Agents
pubmed:status	MEDLINE
pubmed:month	Apr
pubmed:issn	0315-162X
pubmed:author	pubmed-author:AkizukiMasashiM, pubmed-author:AmanoKoichiK, pubmed-author:AsaiTomiakiT, pubmed-author:HamaNobuakiN, pubmed-author:IchikawaYoichiY, pubmed-author:KawaiShinichiS, pubmed-author:KobayashiShigetoS, pubmed-author:KondoHirobumiH, pubmed-author:MatsubaraTsukasaT, pubmed-author:MatsuokaYasuoY, pubmed-author:MimoriTsuneyoT, pubmed-author:MurataNorikazuN, pubmed-author:OshimaHisajiH, pubmed-author:SaitoTerunobuT, pubmed-author:Study Group for the Japanese Ministry of Health, Labor and Welfare..., pubmed-author:SuzukiYasuoY, pubmed-author:TanakaYasushiY, pubmed-author:YamadaHidehiroH, pubmed-author:YamamotoSumikiS, pubmed-author:YamanakaHisasiH
pubmed:issnType	Print
pubmed:volume	37
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	723-9
pubmed:meshHeading	pubmed-meshheading:20194455-Antirheumatic Agents, pubmed-meshheading:20194455-Arthritis, Rheumatoid, pubmed-meshheading:20194455-Disease Progression, pubmed-meshheading:20194455-Double-Blind Method, pubmed-meshheading:20194455-Humans, pubmed-meshheading:20194455-Joints, pubmed-meshheading:20194455-Predictive Value of Tests, pubmed-meshheading:20194455-Prognosis, pubmed-meshheading:20194455-Regression Analysis, pubmed-meshheading:20194455-Sensitivity and Specificity, pubmed-meshheading:20194455-Severity of Illness Index, pubmed-meshheading:20194455-Treatment Outcome
pubmed:year	2010
pubmed:articleTitle	Clinical activity after 12 weeks of treatment with nonbiologics in early rheumatoid arthritis may predict articular destruction 2 years later.
pubmed:affiliation	Department of Rheumatic, Collagen and Allergic Diseases, St. Marianna University School of Medicine, Kawasaki, Japan.
pubmed:publicationType	Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't